Anavex Life Sciences, a renowned biopharmaceutical company, is making significant strides in the development of therapeutics for neurological disorders. Focused on conditions like Alzheimer’s disease and Parkinson’s disease, the company’s research and development efforts are fast gaining worldwide attention.  At the heart of the Anavex Life Sciences’ innovative pursuits is their lead drug candidate, ANAVEX®2-73, […]